Protease-activated Receptor-1 Antagonists

*Prices reflect U.S. average retail price

Zontivity (vorapaxar)

VORAPAXAR helps to prevent blood clots. It is used in patients with a previous heart attack or blockages in the arteries of the legs to reduce the risk of heart attack, stroke, or the need for procedures to restore blood flow to the heart.

 

Manufacturer's Website: Zontivity

 

Average retail cost: $516/month

Copyright  2006-2023  Automated Clinical Guidelines, LLC.  All rights reserved.